Treatment of self-mutilation with olanzapine

Journal of Cutaneous Medicine and Surgery

Volumn 4, Issue 3, 2000, Pages 160-162

  Garnis Jones, Sylvia ^a,b   Collins, Stephen ^a   Rosenthal, Donald ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

ADULT; ARTICLE; AUTOMUTILATION; CASE REPORT; CONTACT DERMATITIS; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; FACTITIOUS DISEASE; FEMALE; HUMAN; IMPULSIVENESS; LIFE EVENT; MALE; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0033856060     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347540000400310     Document Type: Article

References (13)

1. Psychiatric aspects of dermatitis artefacta
2. What is dermatitis artefacta?
3. Dermatitis artefacta
4. Current concepts in psychiatry: Panic attacks and phobias
5. Self-inflicted injury: A follow-up study of 43 patients
6. Obsessive-compulsive disorders: A review of the literature
7. Basic pharmacokinetics principles and their application to psychotropic drugs
8. Clinical use of the newer antipsychotic drugs
9. Olanzapine vs. haloperidol in the treatment of schizophrenia, schizoaffective and schizophreniform disorders: Results of an international collaborative trial
10. Adverse effects of antipsychotic drugs
11. 2 receptor occupancy of clozapine, rispiridone, and olanzapine in schizophrenia
12. Anticonvulsants and antipsychotics in the treatment of bipolar disorder
13. Pharmacological profile of rispiridone